Evidence-Based Medicine Guidelines
Orlistat and sibutramine for obesity and overweight
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Orlistat and Sibutramine for Obesity and Overweight." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456729/all/Orlistat_and_sibutramine_for_obesity_and_overweight.
Orlistat and sibutramine for obesity and overweight. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456729/all/Orlistat_and_sibutramine_for_obesity_and_overweight. Accessed April 25, 2024.
Orlistat and sibutramine for obesity and overweight. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456729/all/Orlistat_and_sibutramine_for_obesity_and_overweight
Orlistat and Sibutramine for Obesity and Overweight [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456729/all/Orlistat_and_sibutramine_for_obesity_and_overweight.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Orlistat and sibutramine for obesity and overweight
ID - 456729
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456729/all/Orlistat_and_sibutramine_for_obesity_and_overweight
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
